Literature DB >> 11861515

Rapid nongenomic E2 effects on p42/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes.

Esther Garcia Dos Santos1, Marie Noëlle Dieudonne, René Pecquery, Vincent Le Moal, Yves Giudicelli, Danièle Lacasa.   

Abstract

In some tissues, rapid effects of estrogens have been described at the plasma membrane level including activation of the MAPK activity. In rat adipocytes, the present study demonstrates that physiological concentrations (0.1-10 nM) of E2 rapidly activate the p42/p44 MAPK. This effect was blocked by the pure estrogen antagonist, ICI 182 780, and appeared specific for E2 because 17alpha-E2, T, and progesterone failed to change the MAPK activity. Pertussis toxin; PP2, a selective inhibitor of Src family kinase; and wortmannin all reduced the magnitude of MAPK activation by E2 suggesting involvement of the Gi-protein/Src family kinase/PI3K pathway. Classical PKCs and MAPK kinase were also involved in MAPK activation by E2. Interestingly, this activation was observed in late but not early differentiated rat preadipocytes, and the immunoreactive ER(alpha) protein was detected only in adipocyte membrane, suggesting that the adipocyte membrane structure is required for the nongenomic effect of E2. Moreover, E2 induced a rapid nuclear translocation of MAPK together with a fast MAPK- dependent activation of cAMP response element binding protein leading to a transcriptional activation of cAMP response element binding protein-responsive genes and reported plasmids. However, the E2 increase in adipocyte activator protein-1 DNA binding does not seem to be fully explained by the E2 activation of the MAPK pathway. This study provides clear evidence for an additional nongenomic mechanism whereby estrogens may exert their control on adipose tissue metabolism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861515     DOI: 10.1210/endo.143.3.8678

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  29 in total

1.  Intravenous estrogens increase insulin clearance and action in postmenopausal women.

Authors:  R E Van Pelt; W S Gozansky; R S Schwartz; W M Kohrt
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-04-08       Impact factor: 4.310

2.  GPRC6A mediates the non-genomic effects of steroids.

Authors:  Min Pi; Abby L Parrill; L Darryl Quarles
Journal:  J Biol Chem       Date:  2010-10-13       Impact factor: 5.157

Review 3.  Extranuclear signaling by estrogen: role in breast cancer progression and metastasis.

Authors:  V Cortez; M Mann; D W Brann; R K Vadlamudi
Journal:  Minerva Ginecol       Date:  2010-12

4.  Acute modulation of adipose tissue lipolysis by intravenous estrogens.

Authors:  Rachael E Van Pelt; Wendolyn S Gozansky; Robert C Hickner; Robert S Schwartz; Wendy M Kohrt
Journal:  Obesity (Silver Spring)       Date:  2006-12       Impact factor: 5.002

5.  Rapid actions of plasma membrane estrogen receptors regulate motility of mouse embryonic stem cells through a profilin-1/cofilin-1-directed kinase signaling pathway.

Authors:  Seung Pil Yun; Jung Min Ryu; Mi Ok Kim; Jae Hong Park; Ho Jae Han
Journal:  Mol Endocrinol       Date:  2012-06-25

6.  Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos.

Authors:  Jennifer H Gutzman; Sarah E Nikolai; Debra E Rugowski; Jyoti J Watters; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2005-03-03

7.  Gender-specific expression and mechanism of regulation of estrogen sulfotransferase in adipose tissues of the mouse.

Authors:  Victor K Khor; Ming Han Tong; Yueming Qian; Wen-Chao Song
Journal:  Endocrinology       Date:  2008-07-31       Impact factor: 4.736

8.  Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways.

Authors:  Nataliya N Bulayeva; Bahiru Gametchu; Cheryl S Watson
Journal:  Steroids       Date:  2004-03       Impact factor: 2.668

9.  Membrane-initiated actions of estradiol (E2) in the regulation of LH secretion in ovariectomized (OVX) ewes.

Authors:  J Alejandro Arreguin-Arevalo; Ryan L Ashley; Elizabeth R Wagenmaker; Amy E Oakley; Fred J Karsch; Terry M Nett
Journal:  Reprod Biol Endocrinol       Date:  2010-05-10       Impact factor: 5.211

Review 10.  Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action.

Authors:  C K Osborne; A Wakeling; R I Nicholson
Journal:  Br J Cancer       Date:  2004-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.